Rela Mohamed, Dhawan Anil
Institute of Liver Studies, Department of Child Health King's College Hospital, Denmark Hill, London, England.
Indian J Pediatr. 2002 Feb;69(2):175-83. doi: 10.1007/BF02859381.
The results of liver transplantation has improved significantly in the last decade with one year survival figures close to 90% for children with chronic liver disease. This can be attributed to improvement in surgical techniques, better postoperative care and newer immunosuppresive drugs. As a result of this, increasing number of children are referred for transplantation with no significant increase in the number of solid organ donors. The earliest transplants in children were performed using organs from size matched pediatric donors. However, as the pediatric donor numbers were limited, liver reduction techniques were developed to transplant small children before deterioration. Increasing experience with reduced livers led to the development of split liver, living donor and auxiliary liver transplantation. Better management of immunosuppressive drugs and newer agents such as Mycophenolate Mofetil have reduced the incidence of graft loss due to chronic rejection and long-term renal toxicity. The goal for the future will remain to be transplantation without the use of long-term immunosuppression.
在过去十年中,肝移植的结果有了显著改善,患有慢性肝病的儿童一年生存率接近90%。这可归因于手术技术的改进、更好的术后护理以及更新的免疫抑制药物。因此,越来越多的儿童被转诊进行移植,而实体器官供体的数量并未显著增加。儿童最早的移植手术使用的是来自大小匹配的儿科供体的器官。然而,由于儿科供体数量有限,人们开发了肝脏缩小技术,以便在病情恶化前为幼儿进行移植。对缩小肝脏的经验不断增加,促成了劈离式肝移植、活体供肝移植和辅助性肝移植的发展。免疫抑制药物的更好管理以及诸如霉酚酸酯等新型药物降低了因慢性排斥反应和长期肾毒性导致的移植物丢失发生率。未来的目标仍将是在不使用长期免疫抑制的情况下进行移植。